FATE
Fate Therapeutics, Inc.NASDAQHealthcare$1.22-1.61%ClosedMarket Cap: $141.8M
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
6
Sales
2
Buy/Sell Ratio
3.00
Total Bought
$0.00
Total Sold
$2.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri Jan 16 | TAHL CINDY | officer: See Remarks | Sell | 100,000 | $0.00 | 487,081 |
| Fri Jan 16 | TAHL CINDY | officer: See Remarks | Sell | 400,000 | $1.05 | 400,000 |
| Fri Jan 16 | Adawi Kamal | officer: Chief Financial Officer | Sell | 25,000 | $0.00 | 100,000 |
| Fri Jan 16 | Adawi Kamal | officer: Chief Financial Officer | Sell | 75,000 | $1.05 | 75,000 |
| Fri Jan 16 | Valamehr Bahram | director, officer: President and CEO | Sell | 1,300,000 | $1.05 | 1,300,000 |
| Fri Jan 16 | Valamehr Bahram | director, officer: President and CEO | Sell | 335,000 | $0.00 | 664,708 |
| Mon Jan 12 | TAHL CINDY | officer: See Remarks | Sell | 10,589 | $1.06 | 387,081 |
| Mon Jan 12 | Valamehr Bahram | director, officer: President and CEO | Sell | 5,190 | $1.07 | 329,708 |
| Tue Oct 21 | Adawi Kamal | officer: Chief Financial Officer | Sell | 375,000 | $1.54 | 375,000 |
| Tue Oct 21 | Adawi Kamal | officer: Chief Financial Officer | Sell | 75,000 | $0.00 | 75,000 |